Viewing Study NCT03117868


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-02-22 @ 4:54 PM
Study NCT ID: NCT03117868
Status: COMPLETED
Last Update Posted: 2020-07-20
First Post: 2017-04-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mortality of Patients Undergoing Fracture of the Upper Extremity u Femur at the University Hospital of Amiens
Sponsor: Centre Hospitalier Universitaire, Amiens
Organization:

Study Overview

Official Title: Mortality of Patients Undergoing Fracture of the Upper Extremity u Femur at the University Hospital of Amiens
Status: COMPLETED
Status Verified Date: 2020-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FESF-Amiens
Brief Summary: Fractures of the upper femur (EFSF) represent a major public health problem in the elderly. Approximately 1.6 million patients are victims each year of an EFSF and this number is increasing as a result of the aging of the population.

In a recent Amiens retrospective study the mortality was estimated to be 22.5% at 1 year of the fracture. In surviving patients, the impact on loss of autonomy and degradation of quality of life is considerable.

The reduction of the incidence of post-operative complications includes the identification of risk factors.

No prospective study in Amiens has investigated the mortality and the study of the variables involved in the prognosis and long-term mortality of these patients.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: